explore -WSS

explore

author：fashion 2025-10-01 01:50:49 - browse：63

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

explore

leisure time

WSS

Philips to halt sales of sleep apnea machines in U.S.

Case highlights the risks of experimental stem cell therapy

10 reasons why health care startups fail

NVIDIA and Google execs on the future of AI and drug discovery

Pancreatic cancer early detection could be helped by AI

Anxious about a speech? A startup wants you to pop a minty cardiac drug

entertainment

explore

focus

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: Live from STAT Breakthrough Summit West

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: Live from STAT Breakthrough Summit West

How one medical school became remarkably diverse

Solving academic medical centers' existential crisis

Hollywood unions extend contract negotiations for actors

Cytokinetics CEO stresses company can launch heart drug on its own

hotspot

The Affordable Care Act has saved billions in health care costs

With measles on the rise, a personal story of a devastating disease

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Why Medicare shouldn’t cover every FDA

Arc Institute generative AI designs new CRISPR systems

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

focus

explore

leisure time

knowledge